2017 Q2 Form 10-Q Financial Statement

#000143774917012353 Filed on July 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $9.346M $9.376M
YoY Change -0.32% -9.53%
Cost Of Revenue $5.015M $4.802M
YoY Change 4.44% -7.01%
Gross Profit $2.192M $2.222M
YoY Change -1.37% -10.04%
Gross Profit Margin 23.45% 23.7%
Selling, General & Admin $1.755M $1.894M
YoY Change -7.35% -3.58%
% of Gross Profit 80.07% 85.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $320.6K $325.2K
YoY Change -1.44% -10.86%
% of Gross Profit 14.62% 14.63%
Operating Expenses $1.755M $1.894M
YoY Change -7.35% -3.58%
Operating Profit $1.294M $1.183M
YoY Change 9.4% -16.18%
Interest Expense $35.19K $47.78K
YoY Change -26.35% -18.87%
% of Operating Profit 2.72% 4.04%
Other Income/Expense, Net -$27.97K -$36.08K
YoY Change -22.48% -20.26%
Pretax Income $1.266M $1.147M
YoY Change 10.41% -16.04%
Income Tax $452.2K $414.8K
% Of Pretax Income 35.72% 36.17%
Net Earnings $813.7K $731.8K
YoY Change 11.18% -4.08%
Net Earnings / Revenue 8.71% 7.81%
Basic Earnings Per Share $0.14 $0.13
Diluted Earnings Per Share $0.14 $0.12
COMMON SHARES
Basic Shares Outstanding 5.854M 5.836M
Diluted Shares Outstanding 5.978M 6.017M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.640M $6.100M
YoY Change 25.25% -27.12%
Cash & Equivalents $7.641M $6.102M
Short-Term Investments
Other Short-Term Assets $324.7K $356.3K
YoY Change -8.88% -12.49%
Inventory $4.836M $4.940M
Prepaid Expenses
Receivables $2.737M $3.066M
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.75M $14.79M
YoY Change 6.52% -13.44%
LONG-TERM ASSETS
Property, Plant & Equipment $6.354M $6.390M
YoY Change -0.56% -4.11%
Goodwill $1.047M $1.047M
YoY Change 0.0% -64.84%
Intangibles $621.1K $665.1K
YoY Change -6.62% 52.84%
Long-Term Investments
YoY Change
Other Assets $66.34K $260.9K
YoY Change -74.57% 80.23%
Total Long-Term Assets $7.725M $9.002M
YoY Change -14.18% -5.7%
TOTAL ASSETS
Total Short-Term Assets $15.75M $14.79M
Total Long-Term Assets $7.725M $9.002M
Total Assets $29.83M $30.18M
YoY Change -1.15% -9.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.887M $1.723M
YoY Change 9.49% 13.98%
Accrued Expenses $1.180M $4.020M
YoY Change -70.65% 0.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.315M $1.266M
YoY Change 3.87% 3.87%
Total Short-Term Liabilities $8.561M $8.135M
YoY Change 5.24% -1.57%
LONG-TERM LIABILITIES
Long-Term Debt $2.195M $3.510M
YoY Change -37.45% -26.49%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.195M $3.510M
YoY Change -37.45% -26.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.561M $8.135M
Total Long-Term Liabilities $2.195M $3.510M
Total Liabilities $10.76M $11.64M
YoY Change -7.63% -10.7%
SHAREHOLDERS EQUITY
Retained Earnings $13.39M $13.17M
YoY Change 1.74% 13.75%
Common Stock $5.680M $5.514M
YoY Change 3.01% -27.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $145.3K
YoY Change -114.04%
Treasury Stock Shares $14.42K
Shareholders Equity $19.07M $18.53M
YoY Change
Total Liabilities & Shareholders Equity $29.83M $30.18M
YoY Change -1.15% -9.35%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $813.7K $731.8K
YoY Change 11.18% -4.08%
Depreciation, Depletion And Amortization $320.6K $325.2K
YoY Change -1.44% -10.86%
Cash From Operating Activities $2.909M $1.900M
YoY Change 53.12% -43.54%
INVESTING ACTIVITIES
Capital Expenditures $76.73K $634.4K
YoY Change -87.91% 230.12%
Acquisitions
YoY Change
Other Investing Activities -$8.297K -$28.18K
YoY Change -70.55% 1432.92%
Cash From Investing Activities -$22.69K -$832.6K
YoY Change -97.27% 661.41%
FINANCING ACTIVITIES
Cash Dividend Paid $702.5K $700.7K
YoY Change 0.26% -2.88%
Common Stock Issuance & Retirement, Net $0.00 $145.3K
YoY Change -100.0% -85.96%
Debt Paid & Issued, Net $321.8K $309.7K
YoY Change 3.93% 3.58%
Cash From Financing Activities -1.024M -1.156M
YoY Change -11.36% -43.49%
NET CHANGE
Cash From Operating Activities 2.909M 1.900M
Cash From Investing Activities -22.69K -832.6K
Cash From Financing Activities -1.024M -1.156M
Net Change In Cash 1.862M -1.988M
YoY Change -193.67% -264.19%
FREE CASH FLOW
Cash From Operating Activities $2.909M $1.900M
Capital Expenditures $76.73K $634.4K
Free Cash Flow $2.833M $1.266M
YoY Change 123.82% -60.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 rmcf Business Combination Shortfall Payment
BusinessCombinationShortfallPayment
1800000
CY2017Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
92691
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
179845
CY2017Q2 rmcf Proceeds From Payments For Sale Or Distribution Of Assets
ProceedsFromPaymentsForSaleOrDistributionOfAssets
-11950
CY2016Q2 rmcf Proceeds From Payments For Sale Or Distribution Of Assets
ProceedsFromPaymentsForSaleOrDistributionOfAssets
2000
CY2017Q2 rmcf Restructuring Settlement And Impairment Provisions Excluding Longlived Assets And Goodwill
RestructuringSettlementAndImpairmentProvisionsExcludingLonglivedAssetsAndGoodwill
CY2016Q2 rmcf Restructuring Settlement And Impairment Provisions Excluding Longlived Assets And Goodwill
RestructuringSettlementAndImpairmentProvisionsExcludingLonglivedAssetsAndGoodwill
60000
CY2015Q2 rmcf Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
2090000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1887040
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1820470
CY2017Q2 rmcf Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
2773601
CY2017Q1 rmcf Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
2663054
CY2017Q2 rmcf Intangible Assets Gross
IntangibleAssetsGross
9176886
CY2017Q1 rmcf Intangible Assets Gross
IntangibleAssetsGross
9168377
CY2017Q2 rmcf Inventory Packaging
InventoryPackaging
65694
CY2017Q1 rmcf Inventory Packaging
InventoryPackaging
66001
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2737412
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3855823
CY2017Q2 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
2957094
CY2017Q1 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
2921585
CY2017Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
792620
CY2017Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
608510
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12600727
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12390839
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5673772
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5539357
CY2017Q2 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
76726
CY2016Q2 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
634426
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134415
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
167774
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
498132
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
487446
CY2017Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
6100
CY2017Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
22147
CY2017Q2 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
42647
CY2017Q1 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
26500
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110546
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
104683
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2017Q2 us-gaap Assets
Assets
29830596
CY2016Q2 us-gaap Assets
Assets
30178596
CY2017Q1 us-gaap Assets
Assets
29418356
CY2017Q2 us-gaap Assets Current
AssetsCurrent
15751637
CY2017Q1 us-gaap Assets Current
AssetsCurrent
15150820
CY2017Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
7725386
CY2017Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
7809605
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5779195
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6194948
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7641457
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6102152
CY2017Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1862262
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-92796
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2017Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
46000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
46000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5854372
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5854372
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5854372
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5854372
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
5854
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
5854
CY2017Q2 us-gaap Cost Of Goods Sold Depreciation And Amortization
CostOfGoodsSoldDepreciationAndAmortization
125616
CY2016Q2 us-gaap Cost Of Goods Sold Depreciation And Amortization
CostOfGoodsSoldDepreciationAndAmortization
102473
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
5014965
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
4801929
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
8052573
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
8193529
CY2017Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-100640
CY2016Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19081
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
514808
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
451171
CY2017Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
959514
CY2017Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
858874
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
194934
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
222751
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
320550
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
325224
CY2017Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
702525
CY2017Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
702525
CY2017Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
702525
CY2016Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
699009
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2017Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
66770
CY2016Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-78660
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2111217
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2000670
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
3299098
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
335037
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
404022
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
427203
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
438912
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
452069
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7467558
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7459049
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5356341
CY2017Q2 us-gaap Franchise Costs
FranchiseCosts
514792
CY2016Q2 us-gaap Franchise Costs
FranchiseCosts
547713
CY2017Q2 us-gaap Franchise Revenue
FranchiseRevenue
2139508
CY2016Q2 us-gaap Franchise Revenue
FranchiseRevenue
2351865
CY2017Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15617
CY2016Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3012
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1128706
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1240058
CY2017Q2 us-gaap Goodwill
Goodwill
1046944
CY2017Q1 us-gaap Goodwill
Goodwill
1046944
CY2017Q2 us-gaap Goodwill Gross
GoodwillGross
1709328
CY2017Q1 us-gaap Goodwill Gross
GoodwillGross
1709328
CY2017Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
662384
CY2017Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
662384
CY2017Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
47891
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
47891
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1265903
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1146588
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
452231
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
414754
CY2017Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
349250
CY2016Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
217123
CY2017Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2017Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
47863
CY2017Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
278380
CY2016Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
118227
CY2017Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1089011
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-714221
CY2017Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
406164
CY2016Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
137352
CY2017Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
68236
CY2016Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
69846
CY2017Q2 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
4735281
CY2017Q1 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
4826172
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
621060
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
632207
CY2017Q2 us-gaap Interest Expense
InterestExpense
35189
CY2016Q2 us-gaap Interest Expense
InterestExpense
47779
CY2017Q2 us-gaap Interest Paid
InterestPaid
26929
CY2016Q2 us-gaap Interest Paid
InterestPaid
35045
CY2017Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2087954
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2137609
CY2017Q2 us-gaap Inventory Net
InventoryNet
4835964
CY2017Q1 us-gaap Inventory Net
InventoryNet
4975779
CY2017Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2931704
CY2017Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3021220
CY2017Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
249388
CY2017Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
249051
CY2017Q2 us-gaap Inventory Write Down
InventoryWriteDown
16896
CY2016Q2 us-gaap Inventory Write Down
InventoryWriteDown
21826
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7218
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
11697
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29830596
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29418356
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8560879
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8060259
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
3509910
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1314613
CY2017Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1302501
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1176370
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1352894
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
980646
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2195297
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2529240
CY2017Q2 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">NOTE <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> - CONTINGENCIES</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company is party to various legal proceedings arising in the ordinary course of business from time to time. Management believes that the resolution of these matters will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a significant adverse effect on the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s financial position, results of operations or cash flows.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2014, </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">SWRL entered into an Asset Purchase Agreement (the &#x201c;CherryBerry Purchase Agreement&#x201d;) with CherryBerry Enterprises LLC, CherryBerry Corporate LLC, CherryBerry LLC, and their respective owners (collectively, the &#x201c;CherryBerry Selling Parties&#x201d;), pursuant to which SWRL acquired the franchise rights of frozen yogurt stores branded as &#x201c;CherryBerry&#x201d; (the &#x201c;CherryBerry Acquisition&#x201d;). As a part of the consideration for the CherryBerry Acquisition, SWRL agreed to issue an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,000,000</div> shares of SWRL common stock (the &#x201c;CB Shares&#x201d;) to the CherryBerry Selling Parties, which were subject to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year lock-up agreement. The CB Shares were issued to the CherryBerry Selling Parties in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2015. </div>Pursuant to the terms of the CherryBerry Purchase Agreement, following expiration of the lock-up period, if any of the CherryBerry Selling Parties desired to sell their CB Shares, they must <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> offer such shares to SWRL and RMCF prior to any sale of the CB Shares on the open market. If the proceeds from the sale of any of the CB Shares is less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.50</div> per share and the CherryBerry Selling Parties comply with other terms of the CherryBerry Purchase Agreement, SWRL agreed to pay a shortfall payment equal to the difference of the sale price of the CB Shares and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.50</div> per share, multiplied by the number of shares sold by the CherryBerry Selling Parties. If SWRL was required to pay the shortfall payment at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2017, </div>the shortfall payment would approximate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,800,000.</div> SWRL determined the likelihood of incurring the liability to be less than probable and has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> </div>recorded a contingent liability at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2017. </div>In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2015, </div>the CherryBerry Selling Parties submitted to SWRL several requests for payment of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$205,000</div> of shortfall payments based on the sale of a portion of the CB Shares. </div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2015, </div>SWRL filed a lawsuit against the CherryBerry Selling Parties, a former officer and director of SWRL and unknown other parties, in the District Court for La Plata County, Colorado, alleging wrongful actions on their part to cause the price of SWRL<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s common stock to decline and thereafter making an improper demand for the shortfall payment described above, and certain other actions in violation of various provisions of the CherryBerry Purchase Agreement. SWRL sought unspecified damages, attorney&#x2019;s fees, other costs, and a determination that the shortfall payment arrangement is void. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 2015, </div>the CherryBerry Selling Parties filed an answer and counterclaim to the lawsuit in the U.S. District Court for the District of Colorado, and moved the lawsuit to federal court in the U.S. District Court for the District of Colorado (the &#x201c;Colorado District Court&#x201d;). In addition, the CherryBerry Entities added RMCF to the lawsuit through a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party complaint. The complaint alleged that SWRL materially breached the CherryBerry Purchase Agreement by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> paying the shortfall payment, that SWRL is the alter ego of RMCF and RMCF is liable for any obligations of SWRL, and that the SWRL Loan Agreement should be recharacterized as equity. The CherryBerry Entities sought payment in full of the shortfall payment under the CherryBerry Purchase Agreement, declaratory judgements that SWRL is the alter ego of RMCF and the SWRL Loan Agreement should be recharacterized as equity, and interest, attorney&#x2019;s fees, costs and other equitable relief. </div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 13, 2016, </div>the CherryBerry Entities dismissed without prejudice their counterclaim and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party complaint in the Colorado District Court, and thereafter on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 13, 2016, </div>the CherryBerry Entities refiled the exact claims (the &#x201c;Oklahoma Action&#x201d;) in the United States District Court for the Northern District of Oklahoma (the &#x201c;Oklahoma Court&#x201d;). Also on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 13, 2016, </div>RMCF filed a lawsuit against the CherryBerry Entities in the Colorado District Court seeking a declaratory judgment that it is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> the alter ego of SWRL and that the SWRL Loan Agreement should <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be re-characterized as equity (the &#x201c;Colorado Action&#x201d;). On that same date, SWRL filed a complaint against the CherryBerry Selling Parties asserting the same claims as it had asserted previously. RMCF filed a motion to dismiss for lack of jurisdiction and improper venue and in the alternative a motion to transfer venue in response to the Oklahoma Action, and the CherryBerry Selling Parties subsequently filed a motion to dismiss the Colorado Action. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2016, </div>the Colorado District Court granted in part the CherryBerry Selling Parties<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019; motion and administratively closed the case. In addition, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2016, </div>the Oklahoma Court denied RMCF&#x2019;s motion (and SWRL&#x2019;s similar motion). On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 8, 2016, </div>the CherryBerry Entities moved to add RMCF as a defendant on the alter ego and re-characterization claims in the Oklahoma Action. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 9, 2016, </div>the Oklahoma Court granted that application and we filed an answer to this action on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 6, 2016. </div>All parties are currently involved in discovery proceedings relating to this matter. A trial date has been set to commence on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 18, 2017. </div>We intend to vigorously assert and defend our rights in this lawsuit.</div></div></div>
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1024355
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1155655
CY2017Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-22691
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-832555
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2909308
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1895414
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
813672
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
731834
CY2017Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
212136
CY2017Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
235612
CY2017Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
296245
CY2017Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
370769
CY2017Q2 us-gaap Notes Payable
NotesPayable
3509910
CY2017Q1 us-gaap Notes Payable
NotesPayable
3831741
CY2017Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2017Q2 us-gaap Number Of Stores
NumberOfStores
530
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1293874
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1182670
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
392179
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
253497
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
324668
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
256548
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
66342
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74639
CY2017Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
315407
CY2016Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
240031
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27971
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36082
CY2017Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-8297
CY2016Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-28175
CY2017Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
145273
CY2017Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
702524
CY2016Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
700728
CY2017Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
8508
CY2016Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
272956
CY2017Q2 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
CY2016Q2 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
36000
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76726
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
634426
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
66196
CY2016Q2 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
80652
CY2017Q2 us-gaap Profit Loss
ProfitLoss
813672
CY2016Q2 us-gaap Profit Loss
ProfitLoss
731834
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18954300
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18848770
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6353573
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6457931
CY2017Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29400
CY2016Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29400
CY2017Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
321831
CY2016Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
309654
CY2017Q2 us-gaap Restructuring Charges
RestructuringCharges
0
CY2017Q2 us-gaap Retail Expenses
RetailExpenses
572824
CY2016Q2 us-gaap Retail Expenses
RetailExpenses
666949
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13394794
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13283646
CY2017Q2 us-gaap Revenues
Revenues
9346447
CY2016Q2 us-gaap Revenues
Revenues
9376199
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
7206939
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
7024334
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
626352
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
654129
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
134415
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
167774
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
560
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.21
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.22
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
123658
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
181742
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
123098
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
181742
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12936
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12936
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y357D
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y354D
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2016Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2014Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000
CY2015Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
2058000
CY2017Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
638000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
19074420
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
18828857
CY2017Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
123366
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
181742
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5977738
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6017257
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5854372
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5835515

Files In Submission

Name View Source Status
0001437749-17-012353-index-headers.html Edgar Link pending
0001437749-17-012353-index.html Edgar Link pending
0001437749-17-012353.txt Edgar Link pending
0001437749-17-012353-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmcf-20170531.xml Edgar Link completed
rmcf-20170531.xsd Edgar Link pending
rmcf-20170531_cal.xml Edgar Link unprocessable
rmcf-20170531_def.xml Edgar Link unprocessable
rmcf-20170531_lab.xml Edgar Link unprocessable
rmcf-20170531_pre.xml Edgar Link unprocessable
rmcfd20170531_10q.htm Edgar Link pending
rmcfd20170531_10qimg001.jpg Edgar Link pending
Show.js Edgar Link pending